14 October 2024
14 October 2024
The study aims to assess the Catheter and Affera system in patients who have ventricular tachycardia (VT) due to scarring from a previous myocardial infarction.
MachineMD claims its Neos VR headset is the first EU MDR-approved device for the performance of in-depth visual exams.
The company has reported 181 adverse events because of a defect.
The qualitative test assesses Claudin 18 protein expression in gastric adenocarcinoma.
Abbott has completed enrollment in one device study, and kicked off another for a dual-energy catheter.
The Merlin test categorises melanoma patients by sentinel lymph node (SLN) metastasis risk, aiding effective risk-based decision-making.
Si-Bone’s TNT implant system secured 510(k) clearance from the US Food and Drug Administration (FDA) in August 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
